Exceptional sustained responses to ipilimumab/nivolumab (ipi/nivo) in patients (
- This topic has 0 replies, 1 voice, and was last updated 3 years, 11 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Exceptional sustained responses to ipilimumab/nivolumab (ipi/nivo) in patients (pts) with advanced pancreaticobiliary cancers and germline DNA damage repair (DDR) mutations.
https://meetinglibrary.asco.org/record/186401/abstract
Viewing 1 post (of 1 total)
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.